Table 3.
Body Weight | |||
---|---|---|---|
Experimental Groups | Initial Weight | Final Weight | Weight Gain (+) or Loss (−) |
Normal control (2% tween 80%) | 377.00±8.05 | 385.67±7.47 | 8.67±4.22 |
Negative control CP(200mg/kg i.p) | 381.50±5.75 | 363.33±4.68 | −18.17±3.05a** |
Positive control (EN10mg/kg/Po) | 350.50±6.74 | 343.67±7.37 | −2.50±9.25 |
CE(100mg/kg)+CP(200mg/kg) | 372.67±9.38 | 358.17±9.38 | −14.5±3.87a* |
CE(200mg/kg)+CP(200mg/kg) | 355.50±9.01 | 341.33±7.64 | −14.17±2.98a* |
CE(400mg/kg)+CP(200mg/kg) | 356.83±6.16 | 355.83±6.24 | −1.00±3.44 |
AF(200mg/kg)+ CP(200mg/kg) | 360.50±9.25 | 346.00±8.02 | −14.55±2.06a* |
AF(400mg/kg)+ CP(200mg/kg) | 365.33±7.32 | 351.00±8.58 | −14.17±2.57a* |
HF(200mg/kg)+ CP(200mg/kg) | 372.00±8.10 | 357.00±7.14 | −15.00±2.65a* |
HF(400mg/kg)+ CP(200mg/kg) | 384.33±0.80 | 370.00±5.11 | −14.33±4.54a* |
Notes: Mean ±SEM (n= 6); analysis was performed using one-way ANOVA followed by Tukey post hoc test; aCompared with normal control: *p<0.05, **p<0.01.
Abbreviations: AF, aqueous fraction; CE, crude extract; CP, cyclophosphamide; EN, enalapril; HF, hexane fraction; SEM, standard error of mean; Wt., weight.